Although secondary effects of these treatment regimens, such as LPS-mediated (cyto-)toxicity and/or tolerisation, cannot be excluded, the outcome of these experiments also point to a role of TLR4 in the development of diabetes in the NOD mouse. The gene discussed is TLR4; the disease is diabetes mellitus.